United States Authorizes Resumption of Vaccination with Johnson & Johnson Against COVID-19

The US health authorities gave the green light on Friday to the resumption of immunization against covid-19 with the vaccine of Johnson & Johnson on USA, which was suspended on April 13 after rare cases of thrombosis.

”The use of the vaccine against covid-19 Janssen should be resumed in the United States ”, The Centers for Disease Control and Prevention (CDC) and the US drug agency, the FDA, said in a joint statement, considering that the benefits of the vaccine outweigh the risks.

The discontinuation of the use of the vaccine developed by the American laboratory had been decided to investigate several cases of women who developed blood clots in association with low levels of platelets after their injection.

“The FDA and CDC are confident that this vaccine is safe and effective in preventing covid-19”the two agencies said.

“At this time, the available data suggests that the risk” thrombosis “It is very low, but the FDA and CDC will remain vigilant and will continue to investigate this risk,” points to the text.

Earlier on Friday, a group of experts had recommended that US health authorities resume vaccination with the product of Johnson & Johnson.